A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea

Clinical trial NCT07018544 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07018544
Sponsor: Novo Nordisk A/S
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Obesity and Overweight

Start date: 2024-11-19
Primary completion: 2027-02-28
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.